Trial Profile
Phase I/II study of RP-323 in patients with Hodgkin's Lymphoma
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 18 Feb 2016
Price :
$35
*
At a glance
- Drugs Tetradecanoylphorbol acetate (Primary)
- Indications Hodgkin's disease
- Focus Therapeutic Use
- Sponsors Rich Pharmaceuticals
- 18 Feb 2016 New trial record